Y-MABS THERAPEUTICS INC (YMAB) Stock Balance Sheet
USA - NASDAQ:YMAB - US9842411095 - Common Stock
8.61 USD
+0.02 (+0.23%)
8.61 USD
0 (0%)
| MRQ (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 62.29M | 67.23M | 78.64M | 105.80M | 181.60M | |||
| Receivables | 15.74M | 19.69M | 22.45M | 12.50M | 7.70M | |||
| Inventories | 9.72M | 7.21M | 5.07M | 6.70M | 5.50M | |||
| Other Current Assets | 4.04M | 4.37M | 4.96M | 5.50M | 7.50M | |||
| Total Current Assets | 91.79M | 98.51M | 111.11M | 130.40M | 202.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.38M | 859.00K | 1.64M | 2.30M | 5.70M | |||
| Intangibles | 2.18M | 2.28M | 2.63M | 3.00M | 1.70M | |||
| Other Non-Current Assets | 19.87M | 18.26M | 12.49M | 5.70M | 3.20M | |||
| Total Non-Current Assets | 25.42M | 21.39M | 16.76M | 11.10M | 10.50M | |||
| TOTAL ASSETS | 117.21M | 119.90M | 127.87M | 141.50M | 212.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 15.37M | 17.04M | 14.07M | 14.10M | 14.30M | |||
| Accounts Payable | 7.57M | 6.66M | 6.06M | 14.20M | 13.60M | |||
| Total Current Liabilities | 22.95M | 23.70M | 20.13M | 28.30M | 27.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 6.77M | 4.20M | 6.76M | 4.00M | 4.80M | |||
| Total Non-Current Liabilities | 6.77M | 4.20M | 6.76M | 3.90M | 4.80M | |||
| TOTAL LIABILITIES | 29.72M | 27.90M | 26.88M | 32.20M | 32.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -495.57M | -487.14M | -457.47M | -436.00M | -340.50M | |||
| Additional Paid In Capital | 583.67M | 576.87M | 558.00M | 543.90M | 519.20M | |||
| Common Shares | 5.00K | 4.00K | 4.00K | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -612.00K | 2.26M | 449.00K | 1.30M | 1.40M | |||
| Shares Outstanding | 45.44M | 44.99M | 43.67M | 43.70M | 43.70M | |||
| Tangible Book Value per Share | 1.88 | 1.99 | 2.25 | 2.43 | 4.08 | |||
| Total Shareholders' Equity | 87.49M | 92.00M | 100.98M | 109.20M | 180.10M | |||
| TOTAL LIABILITIES AND EQUITY | 117.21M | 119.90M | 127.87M | 141.50M | 212.80M | |||
| Statistics | ||||||||
| Current Ratio | 4.00 | 4.16 | 5.52 | 4.61 | 7.25 | |||
| Return On Assets (ROA) | -18.96% | -24.74% | -16.76% | -67.54% | -25.98% | |||
| Return On Equity (ROE) | -25.40% | -32.24% | -21.22% | -87.52% | -30.69% | |||
All data in USD , ROIC based on taxRate of 0.21